HomeMarketsSharesSPIRE HEALTHCARE GROUP PLC ORD

Trade SPIRE HEALTHCARE GROUP PLC ORD - SPI CFD

Market is not available at the momentMarket information is presented
as of 2026-10-16T15:28:16+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.01
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02127 %
(-£4.25)

Trade size with leverage ~ £20,000.00

Money from leverage ~ $£19,000.00


-0.02127%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.00064 %
(-£0.13)

Trade size with leverage ~ £20,000.00

Money from leverage ~ $£19,000.00


-0.00064%
Overnight funding adjustment time21:00 (UTC)
CurrencyGBP
Min traded quantity10
Margin5.00%
Stock exchangeGreat Britain
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close2.4675
Open2.4725
1-Year Change2.28%
Day's Range2.4675 - 2.4725

Trade SPIRE HEALTHCARE GROUP PLC ORD - SPI

Spire Healthcare Group (SPI) is the second-largest provider of private healthcare in the UK, where it functions as an independent hospital group. The group provides diagnostics, inpatient, day-case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology and oncology. It also owns and operates Perform, a sports medicine, physiotherapy and rehabilitation brand.

The group was founded in 2007 following the acquisition and rebranding of 25 Bupa hospitals by UK private equity firm Cinven. In 2008, Spire added 10 hospitals when it acquired Classic Hospitals Group from LGV Capital for a total consideration of £145m ($196.2m, €172.7m). 

Spire has continued to expand its hospitals by acquiring Claremont Private Hospital on 1 December 2021. Based in Sheffield, Claremont specialises in orthopaedics, general surgery and neurosurgery. The group now operates 40 hospitals and eight clinics across England, Wales and Scotland.

Spire went public in July 2014 and is listed on the London Stock Exchange under the ticker SIP. 

In 2020, the National Health Service (NHS) patients contributed 47.6% of the company’s revenue. Private medical insurance (PMI) patients accounted for 37.4% of its revenue, while the remaining 15% was from self-pay patients. 

In July 2021, Spire’s shareholders, including Toscafund Asset Management and Fidelity International, rejected a £1.4bn merger proposed by Australian-listed Ramsay Healthcare.

Latest shares articles

BAE Systems stock forecast
BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026
TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready